AI assistant
Sending…
Ocugen, Inc. — Director's Dealing 2017
Jun 6, 2017
32915_dirs_2017-06-06_b469a3f4-284f-4088-8cf4-b98e370119bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HISTOGENICS CORP (HSGX)
CIK: 0001372299
Period of Report: 2017-06-05
Reporting Person: Haut Donald (Chief Business Officer)
More from Ocugen, Inc.
Board/Management Information
2026
Jun 3
Board/Management Information
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Capital/Financing Update
2026
Mar 20
Annual Report
2026
Mar 4